Cronos Group Inc. (NASDAQ:CRON - Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 3,290,000 shares, a drop of 10.6% from the December 15th total of 3,680,000 shares. Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.6% of the company's shares are short sold.
Cronos Group Stock Up 1.0 %
Cronos Group stock traded up $0.02 during trading hours on Friday, hitting $1.99. The stock had a trading volume of 1,401,703 shares, compared to its average volume of 1,270,717. The stock has a market cap of $760.78 million, a price-to-earnings ratio of -15.31, a P/E/G ratio of 1.78 and a beta of 0.97. Cronos Group has a one year low of $1.86 and a one year high of $3.14. The business's 50 day simple moving average is $2.02 and its 200-day simple moving average is $2.17.
Institutional Investors Weigh In On Cronos Group
Large investors have recently added to or reduced their stakes in the business. Mackenzie Financial Corp acquired a new stake in Cronos Group in the second quarter valued at approximately $3,237,000. Barclays PLC acquired a new stake in Cronos Group in the third quarter valued at approximately $97,000. International Assets Investment Management LLC grew its stake in Cronos Group by 119.0% in the third quarter. International Assets Investment Management LLC now owns 41,643 shares of the company's stock valued at $91,000 after acquiring an additional 22,628 shares during the period. Renaissance Technologies LLC grew its stake in Cronos Group by 37.9% in the second quarter. Renaissance Technologies LLC now owns 464,949 shares of the company's stock valued at $1,083,000 after acquiring an additional 127,753 shares during the period. Finally, SeaCrest Wealth Management LLC grew its stake in Cronos Group by 77.3% in the fourth quarter. SeaCrest Wealth Management LLC now owns 189,245 shares of the company's stock valued at $382,000 after acquiring an additional 82,500 shares during the period. Institutional investors and hedge funds own 8.71% of the company's stock.
Cronos Group Company Profile
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.